1.
Murphey MD,
Nomikos GC,
Flemming DJ,
Gannon FH,
Temple HT,
Kransdorf MJ.
From the archives of AFIP - Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation.
Radiographics 2001; 21(5):1283-309
2.
Chakarun CJ,
Forrester DM,
Gottsegen CJ,
Patel DB,
White EA,
Matcuk GR Jr.
Giant cell tumor of bone: review,
mimics,
and new developments in treatment.
Radiographics 2013; 33(1):197-211
3.
Greenspan A.
Orthopedic Imaging: a practical approach 4th ed.
Lippincott Williams & Wilkins,
2004
4.
Turcotte RE.
Giant cell tumor of bone.
Orthop Clin North Am 2006; 37(1):35–51
5.
Helms CA.
Fundamentals of Skeletal Radiology 3rd ed.
Elsevier,
2005
6.
Gee V,
Pugh D.
Giant-Cell Tumor of Bone.
Radiology 1958; 10 (1):33-45
7.
Aoki J,
Tanikawa H,
Ishii K,
et al.
MR findings indicative of hemosiderin in giant-cell tumor of bone: frequency,
cause,
and diagnostic significance.
Am J Roentgenol.
1996; 166(1):145-8
8.
Zhen W,
Yaotian H,
Songjian L,
Ge L,
Qingliang W.
Giant-cell tumour of bone: the long-term results of treatment by curettage and bone graft.
J Bone Joint Surg Br 2004; 86(2):212–216
9.
Xu SF,
Adams B,
Yu XC,
Xu M.
Denosumab and giant cell tumour of bone - a review and future management considerations.
Curr Oncol.
2013; 20(5):e442-e447
10.
Thomas D,
Henshaw R,
Skubitz K,
et al.
Denosumab in patients with giant-cell tumour of bone: an open-label,
phase 2 study.
Lancet Oncol 2010; 11(3): 275–280
11.
Dahlin DC.
Caldwell Lecture: giant cell tumor of bone—highlights of 407 cases.
Am J Roentgenol 1985;144(5):955–960